For the Inventor, By the Inventor

Enter assignee name

Vacaville, CA, United States of America

Biosource Technologies, Inc.

USPTO Granted Patents = 25

Trademarks = 1

Forward Citations = 473

Loading Chart...

Loading Chart...

24 inventors (with patents filed for the assignee):

Thomas H Turpen (13 out of 35 patents)

Stephen J Garger (11 out of 31 patents)

Laurence K Grill (9 out of 21 patents)

4. Genadie G Sverlow (9 out of 10 patents)

5. Guy Richard della-Cioppa (7 out of 8 patents)

6. Michael J McCulloch (6 out of 21 patents)

7. Monto H Kumagai (5 out of 20 patents)

8. William O Dawson (4 out of 18 patents)

9. Ann Myers Turpen (4 out of 8 patents)

10. Jon Donson (4 out of 7 patents)

11. Richard Barry Holtz (4 out of 7 patents)

12. David L Berliner (3 out of 35 patents)

13. R Barry Holtz (3 out of 14 patents)

14. David R McGee (3 out of 10 patents)

15. George L Granthan (3 out of 4 patents)

Core Competencies:

Recombinant Nucleic Acids

Viral Amplification

Melanin Production

Transgenic Plants

Soluble Proteins

Tyrosinase

Gene Expression

Pichia Pastoris

Viral Coat Proteins

Therapeutic Uses

Flavoring Materials

Streptomyces

25 patents: Sort by Forward Citations

1. 6054566 - Recombinant animal viral nucleic acids (2000-04-25),

2. 6037456 - Process for isolating and purifying viruses, soluble proteins and (2000-03-14),

3. 6033895 - Process for isolating and purifying viruses, soluble proteins and (2000-03-07),

4. 5977438 - Production of peptides in plants as viral coat protein fusions (1999-11-02),

5. 5965794 - Viral amplification of recombinant messenger RNA in transgenic plants (1999-10-12),

6. 5922602 - Cytoplasmic inhibition of gene expression (1999-07-13),

7. 5889191 - Viral amplification of recombinant messenger RNA in transgenic plants (1999-03-30),

8. 5889190 - Recombinant plant viral nucleic acids (1999-03-30),

9. 5866785 - Recombinant plant viral nucleic acids (1999-02-02),

10. 5837505 - Melanin production from transformed escherichia coli (1998-11-17),

11. 5817631 - Therapeutic uses of melanin (1998-10-06),

12. 5814495 - Melanin production by streptomyces (1998-09-29),

13. 5811653 - Viral amplification of recombinant messenger RNA in transgenic plants (1998-09-22),

14. 5801047 - Method for making stable extracellular tyrosinase and synthesis of (1998-09-01),

15. 5792649 - Method for making stable, extracellular tyrosinase and synthesis of (1998-08-11),

Company Overview

Biosource Technologies, Inc., based in Vacaville, California, specializes in the development and manufacturing of innovative biotechnological solutions. The company focuses on advancing research in the fields of life sciences and biotechnology, providing products and services that enhance scientific discovery and application. With a commitment to quality and innovation, Biosource Technologies aims to support various sectors, including pharmaceuticals and environmental sciences, through its cutting-edge technologies and expertise.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

25 Patents

#3 in Vacaville, CA

#3,158 in California

#13,370 in US

#25,730 in the World

Vacaville, CA, United States of America

Biosource Technologies, Inc.

Forward Citations = 473

24 inventors:

Thomas H Turpen (13 out of 35 patents)

Stephen J Garger (11 out of 31 patents)

Laurence K Grill (9 out of 21 patents)

4. Genadie G Sverlow (9 out of 10 patents)

5. Guy Richard della-Cioppa (7 out of 8 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Biosource Technologies, Inc.. Retrieved from https://idiyas.com/company/biosource-technologies

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…